ACAD
35.69
-0.87
-2.38%
AEMD
0.196
-0.01
-4.6341%
APRI
1.56
-0.11
-6.59%
ARNA
4.21
-0.1
-2.32%
ATEC
1.31
-0.03
-2.24%
CNAT
6.06
-0.04
-0.66%
CRXM
0.479
-0.017
-3.3333%
CYTX
0.71
-0.19
-21.11%
DXCM
66.2
-1.99
-2.92%
GNMK
9.78
-0.41
-4.02%
HALO
15.12
-0.57
-3.63%
ILMN
187.04
-2.61
-1.38%
INNV
0.149
-0.003
-2.295%
INO
8.27
-0.19
-2.25%
ISCO
0.055
-0.005
-7.563%
ISIS
58.34
-1.32
-2.21%
LGND
77.67
-2.18
-2.73%
LPTN
2.05
+0.05
+2.50%
MBVX
2.94
+0.06
+2.08%
MEIP
2.04
-0.09
-4.23%
MNOV
4
+0.06
+1.52%
MRTX
28.08
-0.2
-0.71%
MSTX
0.547
+0.02
+3.697%
NBIX
35.61
-0.47
-1.30%
NUVA
46.65
+0.99
+2.17%
ONCS
0.269
+0.004
+1.509%
ONVO
4.86
+0.06
+1.25%
OREX
6.61
-0.11
-1.64%
OTIC
27.17
-2.14
-7.30%
QDEL
22.86
-0.22
-0.95%
RCPT
146.09
-7.36
-4.80%
RGLS
12.76
-0.69
-5.13%
RMD
64.61
-1.04
-1.58%
SCIE
0.022
0.00
0.00%
SPHS
0.705
-0.045
-6.000%
SRNE
10.41
-0.31
-2.89%
TROV
8.43
-0.47
-5.28%
VICL
0.908
-0.012
-1.3370%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
-0.08
-5.41%
ACAD
35.69
-0.87
-2.38%
AEMD
0.196
-0.01
-4.6341%
APRI
1.56
-0.11
-6.59%
ARNA
4.21
-0.1
-2.32%
ATEC
1.31
-0.03
-2.24%
CNAT
6.06
-0.04
-0.66%
CRXM
0.479
-0.017
-3.3333%
CYTX
0.71
-0.19
-21.11%
DXCM
66.2
-1.99
-2.92%
GNMK
9.78
-0.41
-4.02%
HALO
15.12
-0.57
-3.63%
ILMN
187.04
-2.61
-1.38%
INNV
0.149
-0.003
-2.295%
INO
8.27
-0.19
-2.25%
ISCO
0.055
-0.005
-7.563%
ISIS
58.34
-1.32
-2.21%
LGND
77.67
-2.18
-2.73%
LPTN
2.05
+0.05
+2.50%
MBVX
2.94
+0.06
+2.08%
MEIP
2.04
-0.09
-4.23%
MNOV
4
+0.06
+1.52%
MRTX
28.08
-0.2
-0.71%
MSTX
0.547
+0.02
+3.697%
NBIX
35.61
-0.47
-1.30%
NUVA
46.65
+0.99
+2.17%
ONCS
0.269
+0.004
+1.509%
ONVO
4.86
+0.06
+1.25%
OREX
6.61
-0.11
-1.64%
OTIC
27.17
-2.14
-7.30%
QDEL
22.86
-0.22
-0.95%
RCPT
146.09
-7.36
-4.80%
RGLS
12.76
-0.69
-5.13%
RMD
64.61
-1.04
-1.58%
SCIE
0.022
0.00
0.00%
SPHS
0.705
-0.045
-6.000%
SRNE
10.41
-0.31
-2.89%
TROV
8.43
-0.47
-5.28%
VICL
0.908
-0.012
-1.3370%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
-0.08
-5.41%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …